Heart Test Labs To Present At The Annual Roth Conference
WESTLAKE, Texas--(BUSINESS WIRE)--Heart Test Laboratories, Inc. announced today that the company is presenting at the 28th Annual Roth Conference, which is being held at the Ritz Carlton in Dana Point, California. Mark Hilz, CEO of Heart Test Laboratories, will be presenting on Tuesday March 15th at 3 p.m. in the Pacific Promenade Room. One-on-one meetings with the company can be scheduled through Roth.
The company has completed the development of its flagship device, the MyoVista, and will be launching the product later this year. The MyoVista’s innovative technology includes proprietary informatics that facilitate enhanced screening for heart disease by physicians.
The company has completed the development of its flagship device, the MyoVista, and will be launching the product later this year. The MyoVista’s innovative technology includes proprietary informatics that facilitate enhanced screening for heart disease by physicians.